2 BIOCHEMICAL MARKERS EFFECTIVELY USED TO SEPARATE SMOKELESS TOBACCO USERS FROM SMOKERS AND NONUSERS

被引:12
作者
HOLIDAY, DB [1 ]
MCLARTY, JW [1 ]
YANAGIHARA, RH [1 ]
RILEY, L [1 ]
SHEPHERD, SB [1 ]
机构
[1] UNIV TEXAS,CTR HLTH,DEPT EPIDEMIOL BIOMATH,TYLER,TX 75710
关键词
D O I
10.1097/00007611-199511000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data from asbestos workers were used to devise a cutpoint classifier to identify subjects as Nonuser (non-tobacco user), Smokeless (exclusive smokeless tobacco user), and Smoker (ignited tobacco user). In some clinical trials and smoking cessation programs, Smokeless should be separated from Smoker. One therefore needs a marker for smoke exposure, such as thiocyanate, since nicotine levels, as measured by cotinine, could be similar in both groups. Levels of cotinine (ng/mL) and thiocyanate (mu mol/L) levels (mean +/- SD) were, respectively: 320.9 +/- 201.1 and 145.9 +/- 63.7 for the Smoker group; 339.1 +/- 327.5 and 32.0 +/- 16.9 for the Smokeless group; and 0.6 +/- 2.6 and 58.2 +/- 33.2 for the Nonuser group. For Nonuser, Smokeless, and Smoker, respectively, the self-reported status was 45.1%, 10.8%, and 44.1%, which was adjusted to 42.2%, 11.6%, and 46.2%; the classifier yielded sensitivities of 100%, 76.1%, and 92.2%; specificities of 96.1%, 97.6%, and 96.4%; and predictive values of 94.9%, 80.6%, and 95.6%. The classifier successfully identified Nonusers, separated Smokeless from Smoker, and determined the prevalence of false reports in our cohort.
引用
收藏
页码:1107 / 1113
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 2003, MULTIVARIATE STAT AN
[2]   COTININE DISPOSITION AND EFFECTS [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P ;
JONES, RT ;
OSMAN, AL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :604-611
[3]   NICOTINE ABSORPTION AND CARDIOVASCULAR EFFECTS WITH SMOKELESS TOBACCO USE - COMPARISON WITH CIGARETTES AND NICOTINE GUM [J].
BENOWITZ, NL ;
PORCHET, H ;
SHEINER, L ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :23-28
[4]   PROBLEMS WITH THIOCYANATE AS AN INDEX OF SMOKING STATUS - A CRITICAL-REVIEW WITH SUGGESTIONS FOR IMPROVING THE USEFULNESS OF BIOCHEMICAL MEASURES IN SMOKING CESSATION RESEARCH [J].
BLISS, RE ;
OCONNELL, KA .
HEALTH PSYCHOLOGY, 1984, 3 (06) :563-581
[5]  
BUTTS WC, 1974, CLIN CHEM, V20, P1344
[6]   PLASMA NICOTINE AND COTININE CONCENTRATIONS IN HABITUAL SMOKELESS TOBACCO USERS [J].
GRITZ, ER ;
BAERWEISS, V ;
BENOWITZ, NL ;
VANVUNAKIS, H ;
JARVIK, ME .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :201-209
[7]  
JARVIS M, 1984, J EPIDEMIOL COMMUN H, V38, P335, DOI 10.1136/jech.38.4.335
[8]   CHANGES IN SERUM THIOCYANATE CONCENTRATION ON STOPPING SMOKING [J].
JUNGE, B .
BRITISH MEDICAL JOURNAL, 1985, 291 (6487) :22-22
[9]   NICOTINE AND ITS METABOLITES - RADIOIMMUNOASSAYS FOR NICOTINE AND COTININE [J].
LANGONE, JJ ;
GJIKA, HB ;
VANVUNAK.H .
BIOCHEMISTRY, 1973, 12 (24) :5025-5030
[10]  
MCLARTY J, 1986, AM J EPIDEMIOL, V124, P538